Literature DB >> 9566865

Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit.

T Kanno1, Y Kanno, L F Chen, E Ogawa, W Y Kim, Y Ito.   

Abstract

A member of the polyomavirus enhancer binding protein 2/core binding factor (PEBP2/CBF) is composed of PEBP2 alphaB1/AML1 (as the alpha subunit) and a beta subunit. It plays an essential role in definitive hematopoiesis and is frequently involved in the chromosomal abnormalities associated with leukemia. In the present study, we report functionally separable modular structures in PEBP2 alphaB1 for DNA binding and for transcriptional activation. DNA binding through the Runt domain of PEBP2 alphaB1 was hindered by the adjacent carboxy-terminal region, and this inhibition was relieved by interaction with the beta subunit. Utilizing a reporter assay system in which both the alpha and beta subunits are required to achieve strong transactivation, we uncovered the presence of transcriptional activation and inhibitory domains in PEBP2 alphaB1 that were only apparent in the presence of the beta subunit. The inhibitory domain keeps the full transactivation potential of full-length PEBP2 alphaB1 below its maximum potential. Fusion of the transactivation domain of PEBP2 alphaB1 to the yeast GAL4 DNA-binding domain conferred transactivation potential, but further addition of the inhibitory domain diminished the activity. These results suggest that the activity of the alpha subunit as a transcriptional activator is regulated intramolecularly as well as by the beta subunit. PEBP2 alphaB1 and the beta subunit were targeted to the nuclear matrix via signals distinct from the nuclear localization signal. Moreover, the transactivation domain by itself was capable of associating with the nuclear matrix, which implies the existence of a relationship between transactivation and nuclear matrix attachment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566865      PMCID: PMC110624          DOI: 10.1128/MCB.18.5.2444

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

Review 1.  Nuclear targeting sequences--a consensus?

Authors:  C Dingwall; R A Laskey
Journal:  Trends Biochem Sci       Date:  1991-12       Impact factor: 13.807

2.  pEF-BOS, a powerful mammalian expression vector.

Authors:  S Mizushima; S Nagata
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

3.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.

Authors:  H Miyoshi; K Shimizu; T Kozu; N Maseki; Y Kaneko; M Ohki
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

4.  The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene.

Authors:  M J Klemsz; S R McKercher; A Celada; C Van Beveren; R A Maki
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

5.  Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development.

Authors:  F Otto; A P Thornell; T Crompton; A Denzel; K C Gilmour; I R Rosewell; G W Stamp; R S Beddington; S Mundlos; B R Olsen; P B Selby; M J Owen
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

6.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

7.  The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor.

Authors:  D E Zhang; C J Hetherington; H M Chen; D G Tenen
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

8.  Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.

Authors:  Z Cao; R M Umek; S L McKnight
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

9.  HTLV-1 Tax has distinct but overlapping domains for transcriptional activation and for enhancer specificity.

Authors:  M Fujii; H Tsuchiya; M Seiki
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

10.  Transcription of T cell receptor beta-chain genes is controlled by a downstream regulatory element.

Authors:  P Krimpenfort; R de Jong; Y Uematsu; Z Dembic; S Ryser; H von Boehmer; M Steinmetz; A Berns
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

View more
  63 in total

1.  A novel snail-related transcription factor Smuc regulates basic helix-loop-helix transcription factor activities via specific E-box motifs.

Authors:  H Kataoka; T Murayama; M Yokode; S Mori; H Sano; H Ozaki; Y Yokota; S Nishikawa; T Kita
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains.

Authors:  W Y Kim; M Sieweke; E Ogawa; H J Wee; U Englmeier; T Graf; Y Ito
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

3.  Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.

Authors:  I Kitabayashi; Y Aikawa; L A Nguyen; A Yokoyama; M Ohki
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

Review 4.  RUNX1-dependent mechanisms in biological control and dysregulation in cancer.

Authors:  Deli Hong; Andrew J Fritz; Jonathan A Gordon; Coralee E Tye; Joseph R Boyd; Kirsten M Tracy; Seth E Frietze; Frances E Carr; Jeffrey A Nickerson; Andre J Van Wijnen; Anthony N Imbalzano; Sayyed K Zaidi; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2018-12-04       Impact factor: 6.384

5.  A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator.

Authors:  R Yagi; L F Chen; K Shigesada; Y Murakami; Y Ito
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

6.  RUNX1 regulates corepressor interactions of PU.1.

Authors:  Zhenbo Hu; Xiaorong Gu; Kristine Baraoidan; Vinzon Ibanez; Arun Sharma; ShriHari Kadkol; Reinhold Munker; Steven Ackerman; Giuseppina Nucifora; Yogen Saunthararajah
Journal:  Blood       Date:  2011-04-25       Impact factor: 22.113

7.  A Src family kinase-Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation.

Authors:  Hui Huang; Andrew J Woo; Zachary Waldon; Yocheved Schindler; Tyler B Moran; Helen H Zhu; Gen-Sheng Feng; Hanno Steen; Alan B Cantor
Journal:  Genes Dev       Date:  2012-07-03       Impact factor: 11.361

8.  HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfaces.

Authors:  Judd F Hultquist; Rebecca M McDougle; Brett D Anderson; Reuben S Harris
Journal:  AIDS Res Hum Retroviruses       Date:  2012-08-13       Impact factor: 2.205

9.  Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strategy.

Authors:  T Okuda; K Takeda; Y Fujita; M Nishimura; S Yagyu; M Yoshida; S Akira; J R Downing; T Abe
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

10.  Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms.

Authors:  Hee-Jun Wee; Gang Huang; Katsuya Shigesada; Yoshiaki Ito
Journal:  EMBO Rep       Date:  2002-09-13       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.